| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 20.51▼ | 20.62▼ | 20.56▼ | 20.28▲ | 21.71▼ |
| MA10 | 20.52▼ | 20.52▼ | 20.44▲ | 20.85▼ | 20.38▲ |
| MA20 | 20.53▼ | 20.50▼ | 20.58▼ | 21.44▼ | 17.81▲ |
| MA50 | 20.49▲ | 20.28▲ | 20.58▼ | 20.47▲ | 24.59▼ |
| MA100 | 20.49▲ | 20.63▼ | 21.17▼ | 17.48▲ | N/A |
| MA200 | 20.38▲ | 21.29▼ | 21.62▼ | 20.86▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.012▼ | 0.007▲ | 0.027▲ | -0.264▼ | 0.909▲ |
| RSI | 47.984▼ | 50.021▲ | 50.376▲ | 47.722▼ | 50.661▲ |
| STOCH | 26.351 | 82.055▲ | 58.110 | 31.460 | 69.751 |
| WILL %R | -78.947▼ | -42.373 | -45.161 | -67.695 | -41.563 |
| CCI | -77.736 | 12.281 | 6.705 | -79.535 | 20.356 |
|
Monday, August 11, 2025 01:20 PM
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced second quarter ...
|
|
Thursday, May 08, 2025 01:52 PM
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 20.44 | 21.38 | 19.67 | 20.51 | 176,800 |
| 14/08/25 | 20.50 | 21.26 | 20.17 | 20.20 | 168,876 |
| 13/08/25 | 19.52 | 21.59 | 19.52 | 21.11 | 197,563 |
| 12/08/25 | 19.97 | 21.11 | 18.94 | 19.22 | 152,690 |
| 11/08/25 | 21.20 | 21.68 | 19.45 | 20.35 | 133,288 |
| 08/08/25 | 22.25 | 22.25 | 21.00 | 21.22 | 66,546 |
| 07/08/25 | 21.48 | 21.69 | 20.88 | 21.46 | 79,297 |
| 06/08/25 | 21.48 | 21.535 | 20.64 | 21.29 | 79,765 |
| 05/08/25 | 21.81 | 21.81 | 21.02 | 21.45 | 139,566 |
| 04/08/25 | 21.90 | 21.90 | 21.51 | 21.72 | 51,183 |
|
|
||||
|
|
||||
|
|